Webcast CME

Current Approaches to the Treatment of Metastatic
Castration-Resistant Prostate Cancer

Webcast Series

Print this Content

Current Approaches to the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) webcasts are a part of the Cleveland Clinic Tumor Board series. The faculty roundtable reviews and discusses the evolving changes in the management of men with locally advanced and metastatic prostate cancer.

Webcasts

Current Approaches to the Treatment of Metastatic Castration-Resistant Prostate Cancer
Terence Friedlander, MD; Elisabeth I. Heath, MD, FACP; Alicia Morgans, MD, MPH
Estimated Time:   1 hour 15 minutes
Release Date:   February 23, 2018
Expiration Date:  February 23, 2019
Type: Webcast
Specialties: Hematology/Oncology, Surgery
Optimal Management of Men with Locally-Advanced and Metastatic Hormone-Sensitive Prostate Cancer
Terence Friedlander, MD; Elisabeth I. Heath, MD, FACP; Andrew J. Stephenson, MD, MBA, FRCSC, FACS; Rahul Tendulkar, MD
Estimated Time:   45 minutes
Release Date:   March 9, 2018
Expiration Date:  March 9, 2019
Type: Webcast
Specialties: Hematology/Oncology, Surgery

Series Objectives

Target Audience

The online series is designed for medical, radiation, and surgical oncologists, urologists, oncology practice managers, doctors of nursing practice, nurse practitioners, physician assistants, oncology clinical pharmacists, oncology advanced practice nurses, and other clinicians involved in oncology care delivery.

Activity Directors

Jame Abraham, MD
Director, Taussig Cancer Institute Breast Oncology Program
Co-Director, Multidisciplinary Breast Cancer Program, Cleveland Clinic
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland Clinic
Cleveland, OH

Jorge A. Garcia, MD, FACP
The Kerscher Family Chair for Clinical Prostate Cancer Research
Department of Hematology/Oncology and Urology
Taussig Cancer Institute
Glickman Urological and Kidney Institute
Cleveland Clinic
Cleveland, OH